Literature DB >> 9475823

Amiodarone-associated granuloma in bone marrow.

H Rosenbaum1, Y Ben-Arie, Z S Azzam, N Krivoy.   

Abstract

BACKGROUND: Amiodarone hydrochloride is classified as a Vaughan Williams class III antiarrhythmic agent, although class I, II, and IV effects may contribute to its favorable antiarrhythmic profile. It is associated with a wide variety of adverse effects, such as hypothyroidism, hyperthyroidism, interstitial pulmonary disease, hepatitis, coagulation disorders, skin photosensitivity, corneal microdeposits, alopecia, peripheral neuropathy, and cardiovascular arrhythmias.
SUBJECTS: Bone marrow aspirations and biopsies were performed on two patients treated with amiodarone, on the first during a follow-up for myelofibrosis and on the second for a suspected lymphoproliferative disorder. Several bone marrow granulomas were found in both patients. The bone marrow specimens for tuberculosis and fungal stains were negative.
CONCLUSIONS: The temporal relationship between the amoidarone therapy and the development of two cases of asymptomatic bone marrow granuloma suggest the possibility that this antiarrhythmic agent is involved in the etiology of these granulomas.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9475823     DOI: 10.1345/aph.17061

Source DB:  PubMed          Journal:  Ann Pharmacother        ISSN: 1060-0280            Impact factor:   3.154


  2 in total

Review 1.  Amiodarone-associated bone marrow granulomas: a report of 2 cases and review of the literature.

Authors:  Tarek Mohamed; Rashmi Sanjay; Tatyana Sycheva; Leo Aish; Douglas Schneider; Thein H Oo
Journal:  Int J Hematol       Date:  2007-02       Impact factor: 2.490

2.  Amiodarone-induced bone marrow granulomas: an unusual cause of reversible pancytopenia.

Authors:  Andrew J Erie; Rebecca F McClure; Alexandra P Wolanskyj
Journal:  Hematol Rep       Date:  2010-09-24
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.